• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SURETEX PROPHYLACTICS (I), LTD. SKYN; POLYISOPRENE LATEX MALE CONDOM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SURETEX PROPHYLACTICS (I), LTD. SKYN; POLYISOPRENE LATEX MALE CONDOM Back to Search Results
Lot Number 1706P30622
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Skin Irritation (2076)
Event Date 01/03/2018
Event Type  Injury  
Manufacturer Narrative
Customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.
 
Event Description
On (b)(6) 2018 customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.
 
Manufacturer Narrative
Customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.On 01/12/2018 - a review of the device history record indicated no deviation or out of specification result from the batch record.Retain samples from the same lot were evaluated for odor.No substantial mal odor was detected.No further assignable cause can be identified from the batch record.On 04/14/2018 - (b)(4) intact pieces sent back to the manufacturer.Testing os samples for odor met requirements.Testing for microbial evaluation for microbial count and total yeast and mold were below limit and test for 5 bacteria showed absence.No root cause can be attributed and with the original investigation, all performance and release criteria met specification.No further action to be taken.
 
Event Description
(b)(6) 2018 customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.
 
Manufacturer Narrative
Customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.On 01/12/2018, a review of the device history record indicated no deviation or out of specification result from the batch record.Retain samples from the same lot were evaluated for odor.No substantial mal odor was detected.No further assignable cause can be identified from the batch record.
 
Event Description
On (b)(6) 2018 customer experienced severe vaginal irritation necessitating trips to the doctor.Customer also states that there was a perfume smell to the condom.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SKYN
Type of Device
POLYISOPRENE LATEX MALE CONDOM
Manufacturer (Section D)
SURETEX PROPHYLACTICS (I), LTD.
74-91 kiadb industrial estate
jigani ii phase,anekal taluk
bangalore karnataka, in-ka 560 1 05
IN  560 105
MDR Report Key7168223
MDR Text Key96501172
Report Number3013388459-2018-00002
Device Sequence Number1
Product Code MOL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 01/12/2018,04/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot Number1706P30622
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/29/2018
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/12/2018
Distributor Facility Aware Date01/03/2018
Device Age1 YR
Event Location Home
Date Report to Manufacturer01/12/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age20 YR
-
-